---
granola_id: 8dd75e18-0177-4bcc-b56b-83e372b059bc
title: "Joe Blundo and Virtue"
type: note
created: 2025-09-08T19:09:57.162Z
updated: 2025-09-15T14:01:59.908Z
attendees:
  - joe@bpc.com
  - sd@virtuevc.com
---
### Brighton Park Capital Background

- $2 billion Fund 1A plus couple hundred million LP co-invest
- Check sizes: $20-30M (Series B) to $450M equity
- 40%+ healthcare focus commitment
- Mark (partner, 23 years GA experience) led most healthcare investments 2003-2018
	- Portfolio included Oak Street, Multiplan (successful exits)

### Current Healthcare Portfolio & Strategy

- Fund 1 investments:
	- Exalis (CDI, provider-side)
	- Relations (front office automation, post-acute specialties)
	- Indochine (public on BSE, commercialization software)
- Fund 2: High Trust (control investment, cyber-meets-healthcare)
	- Profitable business, didn’t realize was for-profit initially
	- Leverages Brighton Park’s cyber infrastructure expertise

### Investment Focus Areas

- Revenue cycle opportunities:
	- AI-led venture bets in emerging companies
	- Tech-enabling services leaders (pay higher EBITDA multiples)
- Supply chain/procurement (actively seeking)
- Payment integrity & fraud, waste, abuse:
	- “Captivity 2.0” - AI-enabled software solutions
	- Prepay focus preferred over postpaid models
	- League at top of target list (remarkable customer feedback)
- Pharmacy cost containment & patient access
- Member experience (fintech-meets-healthcare, payments focus)
- Staffing agencies disruption via software
- Clinical trial patient recruitment (insulated from pharma metadata)

### Companies Discussed

- Financial reconciliation - big if true: Study (STDI)
	- Rebuilding modern Change/Waystar equivalent
	- Powers many respected digital health companies
	- Originally built for auto, stumbled into healthcare
- Olivia Analytics: TCAP backing, prepay fraud/waste/abuse focus
- Onos: Behavioral health FWA, former Bain consultant-led
- MedPlum: YC company, EMR SDK for custom builds
	- Getting interest from Natalie’s company to pharma/CROs
	- Potentially raising currently

### Market Intel & Observations

- Waltz/Eversona deal: Waltz struggling toward end, $6B headline misleading
- Payment acceleration opportunity given reimbursement cuts, MA challenges
- Provider abrasion reduction through faster payments to best providers
- 15-20% agency take rates “infuriating” - software disruption opportunity

Chat with meeting transcript: https://notes.granola.ai/d/8dd75e18-0177-4bcc-b56b-83e372b059bc
